Q1
1.561 dage siden
Ordredybde
Antal
Køb
100
Sælg
Antal
200
Seneste handel
| Tid | Pris | Antal | Købere | Sælgere |
|---|---|---|---|---|
| - | - | - | - |
Højest
2,05VWAP
Lavest
1,96OmsætningAntal
0,1 32.707
VWAP
Højest
2,05Lavest
1,96OmsætningAntal
0,1 32.707
Mæglerstatistik
Ingen data fundet
Corporate Actions
| Næste begivenhed | |
|---|---|
Finanskalender er ikke tilgængelig | |
| Tidligere begivenheder | ||
|---|---|---|
| 2021 Generalforsamling | 15. jun. 2021 | |
| 2021 Q1 | 13. maj 2021 | |
| 2020 Q4 | 25. mar. 2021 | |
| 2020 Årsregnskab | 25. mar. 2021 | |
| 2014 Generalforsamling | 2. jun. 2014 |
Data hentes fra Morningstar
Andre har kigget på
Shareville
Deltag i samtalen med SharevilleBliv en del af vores forum for investorer. Følg andre, og diskuter aktier og fonde.
Log ind
25. jul.25. jul.
30. jan.30. jan.January 14 Phio disclosed in a filing that it was offering 1.06M shares of common stock to several institutional investors. In a concurrent private placement to the same institutional investors, Phio was also issuing unregistered short-term warrants to purchase up to 2.13M shares of common stock. For each share of common stock issued in this registered offering, two accompanying private warrants will be issued to the purchaser thereof. Each warrant will be exercisable for one share of common stock at an exercise price of $3.00 per share, will be immediately exercisable upon issuance and will expire twenty-four months from the date of issuance.- 29. jan.29. jan.These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Phio Pharmaceuticals (PHIO), 39,675% surge in interest Eterna Therapeutics (ERNA), 11,117% surge in interest Salarius Pharmaceuticals (SLRX), 10,853% surge in interest Kairos Pharma (KAPA), 2,805% surge in interest Soligenix (SNGX), 1,913% surge in interest Silexion Therapeutics (SLXN), 1,717% surge in interest Azitra (AZTR), 1,645% surge in interest Black Diamond Therapeutics (BDTX), 1,315% surge in interest iBio (IBIO), 935% surge in interest GT Biopharma (GTBP), 900% surge in interest
- 29. jan.29. jan.Phio Pharmaceuticals is a clinical stage biotechnology company whose proprietary Intasyl RNAi technology is designed to make immune cells more effective in killing tumor cells. “Intasyl is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. INTASYL drugs precisely target specific proteins that reduce the body’s ability to fight cancer, without the need for specialized formulations or drug delivery systems,” the company has stated.
30. jan.30. jan.Hvornår tænker du deres undersøgelser er færdige?
Kommentarerne ovenfor kommer fra Nordnets sociale netværk Shareville og er ikke blevet redigeret eller gennemgået af Nordnet. Det betyder ikke, at Nordnet giver investeringsrådgivning eller investeringsanbefalinger. Nordnet påtager sig ikke noget ansvar for kommentarerne.
Nyheder og Analyser
Der er i øjeblikket ingen nyheder
Nyheder og/eller generelle investeringsanbefalinger eller et uddrag af disse på denne side og i relaterede links er produceret og leveret af den angivne leverandør. Nordnet har ikke deltaget i udarbejdelsen af materialet, og vi har ikke gennemgået eller foretaget ændringer i materialet. Læs mere om investeringsanbefalinger.
Q1
1.561 dage siden
Nyheder og Analyser
Der er i øjeblikket ingen nyheder
Nyheder og/eller generelle investeringsanbefalinger eller et uddrag af disse på denne side og i relaterede links er produceret og leveret af den angivne leverandør. Nordnet har ikke deltaget i udarbejdelsen af materialet, og vi har ikke gennemgået eller foretaget ændringer i materialet. Læs mere om investeringsanbefalinger.
Shareville
Deltag i samtalen med SharevilleBliv en del af vores forum for investorer. Følg andre, og diskuter aktier og fonde.
Log ind
- 25. jul.25. jul.
- 30. jan.30. jan.January 14 Phio disclosed in a filing that it was offering 1.06M shares of common stock to several institutional investors. In a concurrent private placement to the same institutional investors, Phio was also issuing unregistered short-term warrants to purchase up to 2.13M shares of common stock. For each share of common stock issued in this registered offering, two accompanying private warrants will be issued to the purchaser thereof. Each warrant will be exercisable for one share of common stock at an exercise price of $3.00 per share, will be immediately exercisable upon issuance and will expire twenty-four months from the date of issuance.
- 29. jan.29. jan.These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Phio Pharmaceuticals (PHIO), 39,675% surge in interest Eterna Therapeutics (ERNA), 11,117% surge in interest Salarius Pharmaceuticals (SLRX), 10,853% surge in interest Kairos Pharma (KAPA), 2,805% surge in interest Soligenix (SNGX), 1,913% surge in interest Silexion Therapeutics (SLXN), 1,717% surge in interest Azitra (AZTR), 1,645% surge in interest Black Diamond Therapeutics (BDTX), 1,315% surge in interest iBio (IBIO), 935% surge in interest GT Biopharma (GTBP), 900% surge in interest
- 29. jan.29. jan.Phio Pharmaceuticals is a clinical stage biotechnology company whose proprietary Intasyl RNAi technology is designed to make immune cells more effective in killing tumor cells. “Intasyl is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. INTASYL drugs precisely target specific proteins that reduce the body’s ability to fight cancer, without the need for specialized formulations or drug delivery systems,” the company has stated.30. jan.30. jan.Hvornår tænker du deres undersøgelser er færdige?
Kommentarerne ovenfor kommer fra Nordnets sociale netværk Shareville og er ikke blevet redigeret eller gennemgået af Nordnet. Det betyder ikke, at Nordnet giver investeringsrådgivning eller investeringsanbefalinger. Nordnet påtager sig ikke noget ansvar for kommentarerne.
Ordredybde
Antal
Køb
100
Sælg
Antal
200
Seneste handel
| Tid | Pris | Antal | Købere | Sælgere |
|---|---|---|---|---|
| - | - | - | - |
Højest
2,05VWAP
Lavest
1,96OmsætningAntal
0,1 32.707
VWAP
Højest
2,05Lavest
1,96OmsætningAntal
0,1 32.707
Mæglerstatistik
Ingen data fundet
Andre har kigget på
Corporate Actions
| Næste begivenhed | |
|---|---|
Finanskalender er ikke tilgængelig | |
| Tidligere begivenheder | ||
|---|---|---|
| 2021 Generalforsamling | 15. jun. 2021 | |
| 2021 Q1 | 13. maj 2021 | |
| 2020 Q4 | 25. mar. 2021 | |
| 2020 Årsregnskab | 25. mar. 2021 | |
| 2014 Generalforsamling | 2. jun. 2014 |
Data hentes fra Morningstar
Q1
1.561 dage siden
Nyheder og Analyser
Der er i øjeblikket ingen nyheder
Nyheder og/eller generelle investeringsanbefalinger eller et uddrag af disse på denne side og i relaterede links er produceret og leveret af den angivne leverandør. Nordnet har ikke deltaget i udarbejdelsen af materialet, og vi har ikke gennemgået eller foretaget ændringer i materialet. Læs mere om investeringsanbefalinger.
Corporate Actions
| Næste begivenhed | |
|---|---|
Finanskalender er ikke tilgængelig | |
| Tidligere begivenheder | ||
|---|---|---|
| 2021 Generalforsamling | 15. jun. 2021 | |
| 2021 Q1 | 13. maj 2021 | |
| 2020 Q4 | 25. mar. 2021 | |
| 2020 Årsregnskab | 25. mar. 2021 | |
| 2014 Generalforsamling | 2. jun. 2014 |
Data hentes fra Morningstar
Shareville
Deltag i samtalen med SharevilleBliv en del af vores forum for investorer. Følg andre, og diskuter aktier og fonde.
Log ind
- 25. jul.25. jul.
- 30. jan.30. jan.January 14 Phio disclosed in a filing that it was offering 1.06M shares of common stock to several institutional investors. In a concurrent private placement to the same institutional investors, Phio was also issuing unregistered short-term warrants to purchase up to 2.13M shares of common stock. For each share of common stock issued in this registered offering, two accompanying private warrants will be issued to the purchaser thereof. Each warrant will be exercisable for one share of common stock at an exercise price of $3.00 per share, will be immediately exercisable upon issuance and will expire twenty-four months from the date of issuance.
- 29. jan.29. jan.These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Phio Pharmaceuticals (PHIO), 39,675% surge in interest Eterna Therapeutics (ERNA), 11,117% surge in interest Salarius Pharmaceuticals (SLRX), 10,853% surge in interest Kairos Pharma (KAPA), 2,805% surge in interest Soligenix (SNGX), 1,913% surge in interest Silexion Therapeutics (SLXN), 1,717% surge in interest Azitra (AZTR), 1,645% surge in interest Black Diamond Therapeutics (BDTX), 1,315% surge in interest iBio (IBIO), 935% surge in interest GT Biopharma (GTBP), 900% surge in interest
- 29. jan.29. jan.Phio Pharmaceuticals is a clinical stage biotechnology company whose proprietary Intasyl RNAi technology is designed to make immune cells more effective in killing tumor cells. “Intasyl is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. INTASYL drugs precisely target specific proteins that reduce the body’s ability to fight cancer, without the need for specialized formulations or drug delivery systems,” the company has stated.30. jan.30. jan.Hvornår tænker du deres undersøgelser er færdige?
Kommentarerne ovenfor kommer fra Nordnets sociale netværk Shareville og er ikke blevet redigeret eller gennemgået af Nordnet. Det betyder ikke, at Nordnet giver investeringsrådgivning eller investeringsanbefalinger. Nordnet påtager sig ikke noget ansvar for kommentarerne.
Ordredybde
Antal
Køb
100
Sælg
Antal
200
Seneste handel
| Tid | Pris | Antal | Købere | Sælgere |
|---|---|---|---|---|
| - | - | - | - |
Højest
2,05VWAP
Lavest
1,96OmsætningAntal
0,1 32.707
VWAP
Højest
2,05Lavest
1,96OmsætningAntal
0,1 32.707
Mæglerstatistik
Ingen data fundet